CYP2A13

Cytochrome P450, family 2, subfamily A, polypeptide 13, also known as CYP2A13, is a human gene.cite web | title = Entrez Gene: CYP2A13 cytochrome P450, family 2, subfamily A, polypeptide 13| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1553| accessdate = ]

PBB_Summary
section_title =
summary_text = This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. Although its endogenous substrate has not been determined, it is known to metabolize 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a major nitrosamine specific to tobacco. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q.cite web | title = Entrez Gene: CYP2A13 cytochrome P450, family 2, subfamily A, polypeptide 13| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1553| accessdate = ]

References

Further reading

PBB_Further_reading
citations =
*cite journal | author=Fernandez-Salguero P, Gonzalez FJ |title=The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis. |journal=Pharmacogenetics |volume=5 Spec No |issue= |pages= S123–8 |year= 1995 |pmid= 7581481 |doi=
*cite journal | author=Smith G, Stubbins MJ, Harries LW, Wolf CR |title=Molecular genetics of the human cytochrome P450 monooxygenase superfamily. |journal=Xenobiotica |volume=28 |issue= 12 |pages= 1129–65 |year= 1999 |pmid= 9890157 |doi=
*cite journal | author=Nelson DR, Zeldin DC, Hoffman SM, "et al." |title=Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. |journal=Pharmacogenetics |volume=14 |issue= 1 |pages= 1–18 |year= 2004 |pmid= 15128046 |doi=
*cite journal | author=Fernandez-Salguero P, Hoffman SM, Cholerton S, "et al." |title=A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. |journal=Am. J. Hum. Genet. |volume=57 |issue= 3 |pages= 651–60 |year= 1995 |pmid= 7668294 |doi=
*cite journal | author=Hoffman SM, Fernandez-Salguero P, Gonzalez FJ, Mohrenweiser HW |title=Organization and evolution of the cytochrome P450 CYP2A-2B-2F subfamily gene cluster on human chromosome 19. |journal=J. Mol. Evol. |volume=41 |issue= 6 |pages= 894–900 |year= 1996 |pmid= 8587134 |doi=
*cite journal | author=Koskela S, Hakkola J, Hukkanen J, "et al." |title=Expression of CYP2A genes in human liver and extrahepatic tissues. |journal=Biochem. Pharmacol. |volume=57 |issue= 12 |pages= 1407–13 |year= 1999 |pmid= 10353262 |doi=
*cite journal | author=Su T, Bao Z, Zhang QY, "et al." |title=Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. |journal=Cancer Res. |volume=60 |issue= 18 |pages= 5074–9 |year= 2000 |pmid= 11016631 |doi=
*cite journal | author=Zhang X, Su T, Zhang QY, "et al." |title=Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant. |journal=J. Pharmacol. Exp. Ther. |volume=302 |issue= 2 |pages= 416–23 |year= 2002 |pmid= 12130698 |doi=
*cite journal | author=Saito S, Iida A, Sekine A, "et al." |title=Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population. |journal=J. Hum. Genet. |volume=48 |issue= 5 |pages= 249–70 |year= 2003 |pmid= 12721789 |doi= 10.1007/s10038-003-0021-7
*cite journal | author=Wang H, Tan W, Hao B, "et al." |title=Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. |journal=Cancer Res. |volume=63 |issue= 22 |pages= 8057–61 |year= 2004 |pmid= 14633739 |doi=
*cite journal | author=Cauffiez C, Lo-Guidice JM, Quaranta S, "et al." |title=Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility. |journal=Biochem. Biophys. Res. Commun. |volume=317 |issue= 2 |pages= 662–9 |year= 2004 |pmid= 15063809 |doi= 10.1016/j.bbrc.2004.03.092
*cite journal | author=Cheng XY, Chen GL, Zhang WX, "et al." |title=Arg257Cys polymorphism of CYP2A13 in a Chinese population. |journal=Clin. Chim. Acta |volume=343 |issue= 1-2 |pages= 213–6 |year= 2004 |pmid= 15115698 |doi= 10.1016/j.cccn.2004.01.017
*cite journal | author=He XY, Shen J, Ding X, "et al." |title=Identification of critical amino acid residues of human CYP2A13 for the metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen. |journal=Drug Metab. Dispos. |volume=32 |issue= 12 |pages= 1516–21 |year= 2005 |pmid= 15333516 |doi= 10.1124/dmd.104.001370
*cite journal | author=Fujieda M, Yamazaki H, Kiyotani K, "et al." |title=Eighteen novel polymorphisms of the CYP2A13 gene in Japanese. |journal=Drug Metab. Pharmacokinet. |volume=18 |issue= 1 |pages= 86–90 |year= 2005 |pmid= 15618722 |doi=
*cite journal | author=Smith BD, Sanders JL, Porubsky PR, "et al." |title=Structure of the human lung cytochrome P450 2A13. |journal=J. Biol. Chem. |volume=282 |issue= 23 |pages= 17306–13 |year= 2007 |pmid= 17428784 |doi= 10.1074/jbc.M702361200

PBB_Controls
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = yes
update_citations = yes